Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Obstructive Lung Diseases

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    February 2020
  1. ZAIDAN MF, Ameredes BT, Calhoun WJ
    Management of Acute Asthma in Adults in 2020.
    JAMA. 2020;323:563-564.
    PubMed     Text format    


  2. TRIPPLE JW, Ameredes BT, Calhoun WJ
    Outpatient Management of Chronic Asthma in 2020.
    JAMA. 2020;323:561-562.
    PubMed     Text format    


  3. ZORATTI EM, O'Connor GT
    New Therapeutic Strategies for Asthma.
    JAMA. 2020;323:517-518.
    PubMed     Text format    


  4. COLEMAN JM 3RD, Gates KL, Kalhan R
    Home Noninvasive Ventilation for Patients With Chronic Obstructive Pulmonary Disease and Chronic Respiratory Failure.
    JAMA. 2020;323:421-422.
    PubMed     Text format    


  5. WILSON ME, Dobler CC, Morrow AS, Beuschel B, et al
    Association of Home Noninvasive Positive Pressure Ventilation With Clinical Outcomes in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis.
    JAMA. 2020;323:455-465.
    PubMed     Text format     Abstract available


    October 2019
  6. BHATT SP, Schwartz JE, Oelsner EC
    FEV1:FVC Thresholds for Defining Chronic Obstructive Pulmonary Disease-Reply.
    JAMA. 2019;322:1611-1612.
    PubMed     Text format    


  7. HAN X, Zhang Y
    FEV1:FVC Thresholds for Defining Chronic Obstructive Pulmonary Disease.
    JAMA. 2019;322:1611.
    PubMed     Text format    


  8. MILLER MR, Stanojevic S
    FEV1:FVC Thresholds for Defining Chronic Obstructive Pulmonary Disease.
    JAMA. 2019;322:1609-1610.
    PubMed     Text format    


  9. VAZ FRAGOSO CA
    FEV1:FVC Thresholds for Defining Chronic Obstructive Pulmonary Disease.
    JAMA. 2019;322:1610-1611.
    PubMed     Text format    


  10. BAUCHNER H, Golub RM
    Ensuring an Accurate Scientific Record-Retraction and Republication.
    JAMA. 2019;322:1380.
    PubMed     Text format    


  11. RINNE ST, Lindenauer PK, Au DH
    Unexpected Harm From an Intensive COPD Intervention.
    JAMA. 2019;322:1357-1359.
    PubMed     Text format    


  12. ABOUMATAR H, Naqibuddin M, Chung S, Chaudhry H, et al
    Effect of a Hospital-Initiated Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Patients Hospitalized With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.
    JAMA. 2019;322:1371-1380.
    PubMed     Text format     Abstract available


    August 2019
  13. WANG M, Aaron CP, Madrigano J, Hoffman EA, et al
    Association Between Long-term Exposure to Ambient Air Pollution and Change in Quantitatively Assessed Emphysema and Lung Function.
    JAMA. 2019;322:546-556.
    PubMed     Text format     Abstract available


    July 2019
  14. RILEY L, Brantly M, Ataya A
    A Woman With Dyspnea and Bronchiectasis.
    JAMA. 2019 Jul 5. pii: 2737853. doi: 10.1001/jama.2019.8606.
    PubMed     Text format    


    June 2019
  15. VESTBO J, Lange P
    Accuracy of Airflow Obstruction Thresholds for Predicting COPD-Related Hospitalization and Mortality: Can Simple Diagnostic Thresholds Be Used for a Complex Disease?
    JAMA. 2019;321:2412-2413.
    PubMed     Text format    


  16. BHATT SP, Balte PP, Schwartz JE, Cassano PA, et al
    Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality.
    JAMA. 2019;321:2438-2447.
    PubMed     Text format     Abstract available


    May 2019
  17. GARCIA E, Berhane KT, Islam T, McConnell R, et al
    Association of Changes in Air Quality With Incident Asthma in Children in California, 1993-2014.
    JAMA. 2019;321:1906-1915.
    PubMed     Text format     Abstract available


  18. THURSTON GD, Rice MB
    Air Pollution Exposure and Asthma Incidence in Children: Demonstrating the Value of Air Quality Standards.
    JAMA. 2019;321:1875-1877.
    PubMed     Text format    


  19. ABOUMATAR H, Wise RA
    Self-medication as Part of Self-management Plans for Patients With COPD-Reply.
    JAMA. 2019;321:1937.
    PubMed     Text format    


  20. STEURER-STEY C
    Self-medication as Part of Self-management Plans for Patients With COPD.
    JAMA. 2019;321:1937.
    PubMed     Text format    


  21. WISE RA, Chapman KR, Scirica BM, Bhatt DL, et al
    Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease: The ASCENT-COPD Randomized Clinical Trial.
    JAMA. 2019;321:1693-1701.
    PubMed     Text format     Abstract available


    March 2019

  22. Dupilumab (Dupixent) for Asthma.
    JAMA. 2019;321:1000-1001.
    PubMed     Text format    


  23. BRUSTAD N, Eliasen AU, Stokholm J, Bonnelykke K, et al
    High-Dose Vitamin D Supplementation During Pregnancy and Asthma in Offspring at the Age of 6 Years.
    JAMA. 2019;321:1003-1005.
    PubMed     Text format    


    February 2019
  24. RILEY CM, Sciurba FC
    Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease: A Review.
    JAMA. 2019;321:786-797.
    PubMed     Text format     Abstract available


    December 2018
  25. RINNE ST, Lindenauer PK, Au DH
    Intensive Intervention to Improve Outcomes for Patients With COPD.
    JAMA. 2018;320:2322-2324.
    PubMed     Text format    


  26. ABOUMATAR H, Naqibuddin M, Chung S, Chaudhry H, et al
    Effect of a Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Hospitalized Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.
    JAMA. 2018;320:2335-2343.
    PubMed     Text format     Abstract available


    October 2018
  27. CRINER GJ, Celli BR
    Failure of Low-Dose Theophylline to Prevent Exacerbations in Patients With COPD.
    JAMA. 2018;320:1541-1542.
    PubMed     Text format    


  28. DEVEREUX G, Cotton S, Fielding S, McMeekin N, et al
    Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial.
    JAMA. 2018;320:1548-1559.
    PubMed     Text format     Abstract available


  29. BURSTEIN B, Plint AC, Papenburg J
    Use of Radiography in Patients Diagnosed as Having Acute Bronchiolitis in US Emergency Departments, 2007-2015.
    JAMA. 2018;320:1598-1600.
    PubMed     Text format    


    September 2018
  30. SOBIERAJ DM, Baker WL
    SMART in the Management of Patients With Persistent Asthma-Reply.
    JAMA. 2018;320:934.
    PubMed     Text format    


  31. XIA Y, Xia L, Shen H
    SMART in the Management of Patients With Persistent Asthma.
    JAMA. 2018;320:933-934.
    PubMed     Text format    


    August 2018
  32. VOELKER R
    Relieving Severe Emphysema Symptoms.
    JAMA. 2018;320:431.
    PubMed     Text format    


    May 2018
  33. HALES CM, Kit BK, Gu Q, Ogden CL, et al
    Trends in Prescription Medication Use Among Children and Adolescents-United States, 1999-2014.
    JAMA. 2018;319:2009-2020.
    PubMed     Text format     Abstract available


  34. HURLEY K, O'Connor GT
    Serum alpha1-Antitrypsin Concentration in the Diagnosis of alpha1-Antitrypsin Deficiency.
    JAMA. 2018;319:2034-2035.
    PubMed     Text format    


    April 2018
  35. SOBIERAJ DM, Baker WL
    Medications for Asthma.
    JAMA. 2018;319:1520.
    PubMed     Text format    



  36. Benralizumab (Fasenra) for Severe Eosinophilic Asthma.
    JAMA. 2018;319:1501-1502.
    PubMed     Text format    


    March 2018
  37. KRISHNAN JA, Au DH
    Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma.
    JAMA. 2018 Mar 19. pii: 2675735. doi: 10.1001/jama.2018.2029.
    PubMed     Text format    


  38. SOBIERAJ DM, Weeda ER, Nguyen E, Coleman CI, et al
    Association of Inhaled Corticosteroids and Long-Acting beta-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.
    JAMA. 2018 Mar 19. pii: 2675737. doi: 10.1001/jama.2018.2769.
    PubMed     Text format     Abstract available


  39. SOBIERAJ DM, Baker WL, Nguyen E, Weeda ER, et al
    Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis.
    JAMA. 2018 Mar 19. pii: 2675736. doi: 10.1001/jama.2018.2757.
    PubMed     Text format     Abstract available


    November 2017
  40. PRESS VG, Cifu AS, White SR
    Screening for Chronic Obstructive Pulmonary Disease.
    JAMA. 2017;318:1702-1703.
    PubMed     Text format    


  41. WILKE RA, Freeman JW
    Potential Health Implications Related to Fracking.
    JAMA. 2017;318:1645-1646.
    PubMed     Text format    


    October 2017
  42. HORITA N, Nagashima A, Kaneko T
    Long-Acting beta-Agonists (LABA) Combined With Long-Acting Muscarinic Antagonists or LABA Combined With Inhaled Corticosteroids for Patients With Stable COPD.
    JAMA. 2017;318:1274-1275.
    PubMed     Text format     Abstract available


    September 2017
  43. DWYER-LINDGREN L, Bertozzi-Villa A, Stubbs RW, Morozoff C, et al
    Trends and Patterns of Differences in Chronic Respiratory Disease Mortality Among US Counties, 1980-2014.
    JAMA. 2017;318:1136-1149.
    PubMed     Text format     Abstract available


    August 2017
  44. CABITZA F, Rasoini R, Gensini GF
    Unintended Consequences of Machine Learning in Medicine.
    JAMA. 2017;318:517-518.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: